Home Prostate / Prostate Cancer Brachytherapy Market Global Growth By 2026 | Industry Analysis by Size, Trends,...

Brachytherapy Market Global Growth By 2026 | Industry Analysis by Size, Trends, Competitor Strategy, High Emerging, Sales Revenue, Competitive Landscape, Opportunity and Challenges


Brachytherapy is radiotherapy primarily used to treat various kinds of cancer and precisely targeting the cancerous tumor from inside the body. This procedure includes the insertion of radioactive elements inside the cancerous tissue and is positioned in a manner that will attack cancer most efficiently. This treatment is highly effective and reduces the risk of any damage to healthy tissues and organs surrounding the tumor, thereby reducing the potential side effects as well. Brachytherapy is used in the treatment for prostate, cervix, breast, and skin cancers and other types of cancer Moreover, it is often used in combination with chemotherapy drugs to reduce the risk of recurring cancer. Brachytherapy is of two different types namely, permanent and temporary.

Additional information on such research findings can be availed at https://www.coherentmarketinsights.com/ongoing-insight/brachytherapy-market-1175

Increasing prevalence of prostate cancer is projected to boost the growth of the brachytherapy market

A growing number of prostate cancer cases are majorly driving the growth of the brachytherapy market. According to the American Cancer Society, as of 2017, around 161,370 people are estimated to be diagnosed with prostate cancer and around 26,730 deaths are recorded due to prostate cancer in the U.S. Prostate cancer is the third-leading cause of death for men in the U.S. Increasing adoption of high dose rate brachytherapy and the growing prevalence of obesity is the prime factor fueling the market growth. On the other side, side effects associated with radiation therapy such as hair loss, fatigue, appetite, and nausea are projected to hamper the growth of the brachytherapy market.

Market Taxonomy:

The global brachytherapy market is segmented on the basis of type, application, and geography

On the basis of dose type

  • High Dose Rate Brachytherapy
  • Low Dose Rate Brachytherapy

On the basis of application

  • Prostate Cancer
  • Breast Cancer
  • Gynecological Cancer
  • Others

For more Information, Request PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1175

Introduction of innovative breast microseed treatment for breast cancer is projected to propel the growth of the brachytherapy market in North America

On the basis of region, the global brachytherapy market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position, and this can be attributed to the increasing adoption of breast microseed treatment for breast cancer. Using brachytherapy, breast microseed treatment involves the precise placement of radioactive seeds in the breast that slowly release the prescribed dose safely over the period. This is an innovative treatment for early-stage breast cancer, which affects 1 in 8 women in North America. For instance, According to the Centers for Disease Control and Prevention, in 2014, around 236,968 women and 2,141 men were diagnosed with breast cancer in the U.S. Furthermore, the Asia Pacific is expected to be the key region in the global brachytherapy market, owing to the launch of Esteya Machine in 2016, for skin cancer treatment. The treatment uses low energy x-rays to target the cancerous site, with the ability to treat multiple lesions at once and a reduced chance of scarring.

Key players involved in the brachytherapy market include Elekta, Varian Medical Systems, Inc., Theragenics Corporation, Sun Nuclear Corporation, Argon Medical Devices, Eckert & Ziegler BEBIG, IsoRay Medical, Cianna Medical, iCAD Inc., and CIVCO Medical Solutions. The key players are focusing on strategic mergers and acquisitions and the development of innovative products. For instance, IsoRay Inc. in 2016, announced the launch of a pilot a study using the intraoperative placement of cesium-131 permanent interstitial brachytherapy in high-risk recurrent head and neck cancer.

Tailored Information as per niche requirement:

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1175

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: [email protected]
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837


This site uses Akismet to reduce spam. Learn how your comment data is processed.